Worldwide Galectin Inhibitor Therapeutics Market Research Report 2021 by Type, Application, Participants and Countries, Forecast Year to 2026
- PRO4355010
- 115 Pages
- March 2021
- Healthcare
Galectin prevention is the rehabs that functions by interfering the signaling paths of galectin. galectin is a protein, belongs to the family members lectins, that acts upon the galactose having glycoproteins.
Numerous studies reveal that galectin inhibitors can effectively deal with many chronic illness such as fibrosis, cancer cells and inflammatory conditions. the international galectin prevention therapies market is expected to proliferate throughout the projection period because of the boosting frequency of fibrosis and cancer cells, and recurring professional trials by many pharmaceutical firms.
Pandemic coronavirus is thought to have a serious effect on the worldwide galectin inhibitor therapeutics market. there has been an interruption in the supply chain leading to a considerable shortage in the supply of galectin prevention rehabs across the globe.
As coronavirus has ended up being the primary focus, all research institutes, biotech and also pharmaceutical companies are selected in partnership work to take care of covid-19. this has actually led to the changing of their focus as well as additionally all the sources from making other drugs to coronavirus vaccines.
Making sectors are being shuttered worldwide due to lockdown causing an unmatched modern technology and also organization model change.
Galectin prevention therapies market: vehicle drivers and restrictions-
The enhancing frequency of different sorts of cancer cells and ongoing clinical trials are the significant chauffeur of the galectin prevention therapies market. the rising recognition of cancer, specifically in establishing countries is driving the growth of the galectin prevention therapies market.
The raising demand for effective therapy of cancer as well as fibrosis with decreased damaging results is likely to drive the development of the galectin inhibitor therapies market. furthermore, technical innovation and solid R & D activities are likely to increase the worldwide galectin inhibitor therapies market.
However, rigorous policies enforced by governing authorities and also the failing of numerous professional tests are anticipated to limit the development of the galectin inhibitor rehabs market.
Galectin inhibitor therapies market: overview
Based upon the application, the fibrosis section is anticipated to hold a major share in the galectin prevention therapeutics market as a result of the boosting occurrence of the disease around the world. based on the route of administration, the dental course segment is expected to control the galectin inhibitor rehabs market.
Based upon the circulation channel, the hospital pharmacies are expected to be the most lucrative segment in the international galectin inhibitor rehabs market because of the bigger number of patients circulation right into the medical facility.
Galectin inhibitor rehabs market: region-wise overview
The United States and Canada is anticipated to dominate the worldwide galectin inhibitor therapeutics market, as a result of the technical improvement, boosting occurrence of fibrosis as well as cancer cells, rising awareness and also items advancement in the region.
In addition, the raising r& d tasks for galectins associated therapies is most likely to improve the marketplace in the region. Europe is expected to be the following, as a result of the visibility of lots of continuous medical trials in the region.
Asia-pacific is expected to have a rapid development in the international galectin prevention rehabs market over the forecast duration due to the quick economic growth and rising healthcare expense in the region. additionally, enhancing populace and frequency of cancer in nations like China and also India are anticipated to increase the galectin inhibitor rehabs market.
Galectin inhibitor therapies market: essential market individuals
Some of the market individuals in the international galectin prevention therapies market identified throughout the worth chain consist of:
Angion
Mandalmed
G3 pharmaceuticals
Galectin rehabs
Glycomimetics inc.
Galecto biotech
Iteos rehabs
Novartis worldwide ag
Pfizer inc.
Eli lilly
The report covers exhaust evaluation on:
Galectin prevention rehabs market sectors
Galectin prevention rehabs market characteristics
Market size
Supply & demand present trends/issues/challenges
Competition & companies entailed
Modern technology
Worth chain
Regional evaluation consists of:
The United States and Canada (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, UK, Spain)
Eastern Europe (Poland, Russia)
Asia pacific (India, ASEAN, Australia & New Zealand)
China
Japan
Center eastern as well as Africa (GCC Countries, s. Africa, northern Africa)
Report highlights:
Detailed review of moms and dad market
Altering galectin prevention therapies market characteristics in the market
Galectin inhibitor therapies -deepness market division
Historical, existing, as well as predicted market size in terms of volume and worth
Galectin prevention rehabs market patterns as well as advancements
Affordable landscape
Techniques of vital gamers as well as products used
Prospective as well as specific niche sectors, geographical areas displaying appealing development
A neutral perspective on market efficiency
Must-have information for market players to maintain and improve their market impact.
Galectin inhibitor therapies market division
Application
Fibrosis
Cancer cells immunotherapy
Dermatology
Others
Administration
Oral
Parenteral
Others
Distribution channel
Health center pharmacies
On the internet drug stores
Retail pharmacies
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of Galectin Inhibitor Therapeutics by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global Galectin Inhibitor Therapeutics Market-Segmentation
4.1 By Type
…
4.2 By End-User/Application Industry
…
4.3 By Geography
4.3.1 North America Galectin Inhibitor Therapeutics Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America Galectin Inhibitor Therapeutics Production from 2014-2020
4.3.1.2 North America Galectin Inhibitor Therapeutics Consumption from 2014-2020
4.3.1.3 North America Galectin Inhibitor Therapeutics Import and Export from 2014-2020
4.3.1.4 North America Galectin Inhibitor Therapeutics Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America Galectin Inhibitor Therapeutics Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America Galectin Inhibitor Therapeutics Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America Galectin Inhibitor Therapeutics Participants Value ($) and Market Share (%) in 2020
4.3.2 Europe Galectin Inhibitor Therapeutics Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe Galectin Inhibitor Therapeutics Production from 2014-2020
4.3.2.2 Europe Galectin Inhibitor Therapeutics Consumption from 2014-2020
4.3.2.3 Europe Galectin Inhibitor Therapeutics Import and Export from 2014-2020
4.3.2.4 Europe Galectin Inhibitor Therapeutics Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe Galectin Inhibitor Therapeutics Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe Galectin Inhibitor Therapeutics Participants Value ($) and Market Share (%) in 2020
4.3.3 Asia-Pacific Galectin Inhibitor Therapeutics Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific Galectin Inhibitor Therapeutics Production from 2014-2020
4.3.3.2 Asia-Pacific Galectin Inhibitor Therapeutics Consumption from 2014-2020
4.3.3.3 Asia-Pacific Galectin Inhibitor Therapeutics Import and Export from 2014-2020
4.3.3.4 Asia-Pacific Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific Galectin Inhibitor Therapeutics Participants Value ($) and Market Share (%) in 2020
4.3.4 Latin America Galectin Inhibitor Therapeutics Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America Galectin Inhibitor Therapeutics Production from 2014-2020
4.3.4.2 Latin America Galectin Inhibitor Therapeutics Consumption from 2014-2020
4.3.4.3 Latin America Galectin Inhibitor Therapeutics Import and Export from 2014-2020
4.3.4.4 Latin America Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America Galectin Inhibitor Therapeutics Participants Value ($) and Market Share (%) in 2020
4.3.5 Middle East & Africa Galectin Inhibitor Therapeutics Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa Galectin Inhibitor Therapeutics Production from 2014-2020
4.3.5.2 Middle East & Africa Galectin Inhibitor Therapeutics Consumption from 2014-2020
4.3.5.3 Middle East & Africa Galectin Inhibitor Therapeutics Import and Export from 2014-2020
4.3.5.4 Middle East & Africa Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa Galectin Inhibitor Therapeutics Participants Value ($) and Market Share (%) in 2020
5. Global Level Competitive Intelligence – Company Profiles
5.1 Company one
5.1.1 Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 Company one Sales, Growth Rate and Global Market Share from 2014-2020
5.2 Company two
5.2.1 Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Company two Sales, Growth Rate and Global Market Share from 2014-2020
5.3 Company three
5.3.1 Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Company three Sales, Growth Rate and Global Market Share from 2014-2020
5.4 Company four
5.4.1 Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 Company four Sales, Growth Rate and Global Market Share from 2014-2020
5.5 Company five
5.5.1 Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Company five Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Company six
5.6.1 Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Company six Sales, Growth Rate and Global Market Share from 2014-2020
5.7 Company seven
5.7.1 Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 Company seven Sales, Growth Rate and Global Market Share from 2014-2020
5.8 Company eight
5.8.1 Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 Company eight Sales, Growth Rate and Global Market Share from 2014-2020
5.9 Company nine
5.9.1 Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 Company nine Sales, Growth Rate and Global Market Share from 2014-2020
5.10 Company ten
5.10.1 Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.10.2 Company ten Sales, Growth Rate and Global Market Share from 2014-2020
5.11 Company 11
5.11.1 Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2014-2020
5.12 Company 12
5.12.1 Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2014-2020
5.13 Company 13
5.13.1 Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2014-2020
5.14 Company 14
5.14.1 Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2014-2020
5.15 Company 15
5.15.1 Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2014-2020
...
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of Global Galectin Inhibitor Therapeutics Market from 2020-2026
7.1 Future Forecast of Global Galectin Inhibitor Therapeutics Market from 2020-2026 Segment by Regions
7.2 Future Forecast of Global Galectin Inhibitor Therapeutics Market from 2020-2026 Segment by Type
7.3 Future Forecast of Global Galectin Inhibitor Therapeutics Market from 2020-2026 Segment by Application
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
523 Disclaimer
Table Key Data from Secondary Sources
Table Key Data Parameter
Figure Market Size Estimation by End-Use Industry
Figure Market: Data Triangulation
Figure Market Size Estimation: Top-Down Approach
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global Galectin Inhibitor Therapeutics Production and Growth Rate Segment by Product Types from 2014-2020
Table Global Galectin Inhibitor Therapeutics Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure Type 1 of Galectin Inhibitor Therapeutics
Figure Type 2 of Galectin Inhibitor Therapeutics
Figure Type 3 of Galectin Inhibitor Therapeutics
Table Global Galectin Inhibitor Therapeutics Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global Galectin Inhibitor Therapeutics Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Application 1 of Galectin Inhibitor Therapeutics
Figure Application 2 of Galectin Inhibitor Therapeutics
Figure Application 3 of Galectin Inhibitor Therapeutics
Table Global Galectin Inhibitor Therapeutics Production Value ($) by Regions
Table Global Galectin Inhibitor Therapeutics Production Value Share by Regions
Table Global Galectin Inhibitor Therapeutics Production by Regions
Table Global Galectin Inhibitor Therapeutics Production Share by Regions
Table Global Galectin Inhibitor Therapeutics Consumption by Regions
Table Global Galectin Inhibitor Therapeutics Consumption Share by Regions
Figure North America Galectin Inhibitor Therapeutics Production and Growth Rate from 2014-2020
Figure North America Galectin Inhibitor Therapeutics Consumption and Growth Rate from 2014-2020
Table North America Galectin Inhibitor Therapeutics Import and Export from 2014-2020
Table North America Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Type from 2019-2020
Table North America Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Application from 2019-2020
Table North America Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America Galectin Inhibitor Therapeutics Participants Value ($) and Market Share (%) in 2020
Figure Europe Galectin Inhibitor Therapeutics Production and Growth Rate from 2014-2020
Figure Europe Galectin Inhibitor Therapeutics Consumption and Growth Rate from 2014-2020
Table Europe Galectin Inhibitor Therapeutics Import and Export from 2014-2020
Table Europe Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Type from 2019-2020
Table Europe Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Application from 2019-2020
Table Europe Galectin Inhibitor Therapeutics Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe Galectin Inhibitor Therapeutics Participants Value ($) and Market Share (%) in 2020
Figure Asia-Pacific Galectin Inhibitor Therapeutics Production and Growth Rate from 2014-2020
Figure Asia-Pacific Galectin Inhibitor Therapeutics Consumption and Growth Rate from 2014-2020
Table Asia-Pacific Galectin Inhibitor Therapeutics Import and Export from 2014-2020
Table Asia-Pacific Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific Galectin Inhibitor Therapeutics Participants Value ($) and Market Share (%) in 2020
Figure Latin America Galectin Inhibitor Therapeutics Production and Growth Rate from 2014-2020
Figure Latin America Galectin Inhibitor Therapeutics Consumption and Growth Rate from 2014-2020
Table Latin America Galectin Inhibitor Therapeutics Import and Export from 2014-2020
Table Latin America Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Type from 2019-2020
Table Latin America Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Application from 2019-2020
Table Latin America Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America Galectin Inhibitor Therapeutics Participants Value ($) and Market Share (%) in 2020
Figure Middle East & Africa Galectin Inhibitor Therapeutics Production and Growth Rate from 2014-2020
Figure Middle East & Africa Galectin Inhibitor Therapeutics Consumption and Growth Rate from 2014-2020
Table Middle East & Africa Galectin Inhibitor Therapeutics Import and Export from 2014-2020
Table Middle East & Africa Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa Galectin Inhibitor Therapeutics Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa Galectin Inhibitor Therapeutics Participants Value ($) and Market Share (%) in 2020
Table Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company one Sales and Growth Rate from 2014-2020
Figure Company one Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company two Sales and Growth Rate from 2014-2020
Figure Company two Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company three Sales and Growth Rate from 2014-2020
Figure Company three Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company four Sales and Growth Rate from 2014-2020
Figure Company four Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company five Sales and Growth Rate from 2014-2020
Figure Company five Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company six Sales and Growth Rate from 2014-2020
Figure Company six Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company seven Sales and Growth Rate from 2014-2020
Figure Company seven Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company eight Sales and Growth Rate from 2014-2020
Figure Company eight Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company nine Sales and Growth Rate from 2014-2020
Figure Company nine Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company ten Sales and Growth Rate from 2014-2020
Figure Company ten Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 11 Sales and Growth Rate from 2014-2020
Figure Company 11 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 12 Sales and Growth Rate from 2014-2020
Figure Company 12 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 13 Sales and Growth Rate from 2014-2020
Figure Company 13 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 14 Sales and Growth Rate from 2014-2020
Figure Company 14 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 15 Sales and Growth Rate from 2014-2020
Figure Company 15 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global Galectin Inhibitor Therapeutics Value ($) and Growth Rate Forecast by Regions (2020-2026)
Table Global Galectin Inhibitor Therapeutics Production and Growth Rate Forecast by Regions (2020-2026)
Table Global Galectin Inhibitor Therapeutics Consumption and Growth Rate Forecast by Regions (2020-2026)
Table Global Galectin Inhibitor Therapeutics Production and Growth Rate Forecast by Types (2020-2026)
Table Global Galectin Inhibitor Therapeutics Consumption and Growth Rate Forecast by End-User/Applications (2020-2540)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
